Macular Degeneration
Showing NaN - NaN of 24
Macular Degeneration Trial in United Kingdom, United States (BI 754132)
Terminated
- Macular Degeneration
- BI 754132
-
Beverly Hills, California
- +12 more
Aug 23, 2022
Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)
Recruiting
- Macular Degeneration
- Geographic Atrophy
- IONIS-FB-LRx
- Placebo
-
Phoenix, Arizona
- +83 more
Aug 19, 2022
Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)
Terminated
- Dry Age-related Macular Degeneration
- +4 more
-
Phoenix, Arizona
- +28 more
Mar 22, 2022
Natural Progression of Dry Age-related Macular Degeneration
Recruiting
- Dry Age-related Macular Degeneration
- +5 more
-
Phoenix, Arizona
- +65 more
Feb 22, 2021
Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)
Completed
- Dry Age-related Macular Degeneration
- +4 more
- GEM103
-
Phoenix, Arizona
- +11 more
Feb 9, 2021
Macular Degeneration Trial in United States (Abicipar pegol)
Completed
- Macular Degeneration
- Abicipar pegol
-
Gilbert, Arizona
- +17 more
Feb 6, 2018
Macular Degeneration Trial in Australia, Italy, United States (Pazopanib)
Completed
- Macular Degeneration
-
Beverly Hills, California
- +16 more
Oct 31, 2017
Macular Degeneration Trial in United States (NT-501 implant, Sham Procedure)
Completed
- Macular Degeneration
- NT-501 implant
- Sham Procedure
-
Beverly Hills, California
- +7 more
Nov 15, 2016
Macular Degeneration Trial in Worldwide (Regorafenib, ophthalmic oily suspension (BAY73-4506), Sham IVT, Ranibizumab)
Terminated
- Macular Degeneration
- Regorafenib, ophthalmic oily suspension (BAY73-4506)
- +3 more
-
Tucson, Arizona
- +148 more
Jul 25, 2016
Macular Degeneration Trial in Worldwide (rhuFab V2 (ranibizumab))
Completed
- Macular Degeneration
- rhuFab V2 (ranibizumab)
-
Tucson, Arizona
- +81 more
Mar 18, 2014
Macular Degeneration Trial in Canada, United States (ranibizumab, aflibercept injection (VEGF Trap-Eye, BAY86-5321))
Completed
- Macular Degeneration
- ranibizumab
- aflibercept injection (VEGF Trap-Eye, BAY86-5321)
-
Birmingham, Alabama
- +187 more
Dec 20, 2012
Macular Degeneration Trial in United States (aflibercept injection (VEGF Trap-Eye, BAY86-5321))
Completed
- Macular Degeneration
- aflibercept injection (VEGF Trap-Eye, BAY86-5321)
-
Phoenix, Arizona
- +17 more
Jan 27, 2012
Macular Degeneration Trial in Worldwide (Epi-Rad90™ Ophthalmic System, ranibizumab)
Unknown status
- Macular Degeneration
- Epi-Rad90™ Ophthalmic System
- ranibizumab
-
Phoenix, Arizona
- +31 more
Jul 26, 2011
Choroidal Neovascularization, Macular Degeneration Trial in Canada, United States (verteporfin, ranibizumab, dexamethasone)
Completed
- Choroidal Neovascularization
- Macular Degeneration
- verteporfin
- +2 more
-
Mobile, Alabama
- +25 more
May 31, 2011
Macular Degeneration, Choroidal Neovascularization Trial in Canada, United States (Verteporfin Photodynamic Therapy,
Completed
- Macular Degeneration
- Choroidal Neovascularization
- Verteporfin Photodynamic Therapy
- +3 more
-
Tucson, Arizona
- +42 more
Mar 23, 2011
Macular Degeneration, Choroidal Neovascularization Trial in United States (TG100801)
Terminated
- Macular Degeneration
- Choroidal Neovascularization
-
Tucson, Arizona
- +7 more
Mar 25, 2010
Macular Degeneration Trial in Canada, United States (Rheopheresis blood filtration)
Unknown status
- Macular Degeneration
- Rheopheresis blood filtration
-
Beverly Hills, California
- +8 more
Sep 21, 2006